Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Microbiome Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Rebiotix
OpenBiome
Seres Therapeutics
Second Genome
MaaT Pharma
Pfizer
Enterome Bioscience
MicroBiome Therapeutics
Ritter Pharmaceuticals
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Probiotics
Prebiotics
Small Molecules
Biological Drugs
Other
Application:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Microbiome Drugs Industry Overview
-
1.1.1 Microbiome Drugs Market Scope and Market Segments
-
1.1.2 Microbiome Drugs Industry Characteristics
-
1.1.3 Global and China Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Microbiome Drugs Production Value and Growth Rate (2017-2028)
-
1.2 Global Microbiome Drugs Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Probiotics
-
1.2.2 Prebiotics
-
1.2.3 Small Molecules
-
1.2.4 Biological Drugs
-
1.2.5 Other
-
1.3 Global Microbiome Drugs Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital Pharmacies
-
1.3.2 Retail Pharmacies
-
1.3.3 Online Pharmacies
-
1.3.4 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Microbiome Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Microbiome Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Microbiome Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Microbiome Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Microbiome Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Microbiome Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Microbiome Drugs Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Microbiome Drugs Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Microbiome Drugs Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Microbiome Drugs Industry Porter's Five Forces Model Analysis
-
2.2.3 Microbiome Drugs Industry PEST Analysis
-
2.3 Microbiome Drugs Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Microbiome Drugs Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Microbiome Drugs Industry
Chapter 3 Global and China Microbiome Drugs Market, by Manufacturer
-
3.1 Global and China Microbiome Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Microbiome Drugs Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Microbiome Drugs Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Microbiome Drugs Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Microbiome Drugs Market Top 3 Players
Chapter 4 Global and China Microbiome Drugs Market, by Type (2017-2028)
-
4.1 Microbiome Drugs Market Trend, by Type
-
4.2 Global Microbiome Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Microbiome Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Microbiome Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Microbiome Drugs Price Trend, by Type (2017-2028)
-
4.3 China Microbiome Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Microbiome Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Microbiome Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Microbiome Drugs Price Trend, by Type (2017-2028)
Chapter 5 Global and China Microbiome Drugs Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Microbiome Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Microbiome Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Microbiome Drugs Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Microbiome Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Microbiome Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Microbiome Drugs Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Microbiome Drugs Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Microbiome Drugs Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Microbiome Drugs Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Microbiome Drugs Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Microbiome Drugs Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Microbiome Drugs Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Microbiome Drugs Market Analysis
-
7.1 North America Microbiome Drugs Market, by Type
-
7.2 North America Microbiome Drugs Market, by Application
-
7.3 North America Microbiome Drugs Market Analysis and Forecast, by Country
-
7.3.1 United States Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Microbiome Drugs Market Analysis
-
8.1 Europe Microbiome Drugs Market, by Type
-
8.2 Europe Microbiome Drugs Market, by Application
-
8.3 Europe Microbiome Drugs Market Analysis and Forecast, by Country
-
8.3.1 Germany Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Microbiome Drugs Market Analysis
-
9.1 APAC Microbiome Drugs Market, by Type
-
9.2 APAC Microbiome Drugs Market, by Application
-
9.3 APAC Microbiome Drugs Market Analysis and Forecast, by Country
-
9.3.1 China Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Microbiome Drugs Market Analysis
-
10.1 Latin America, Middle East and Africa Microbiome Drugs Market, by Type
-
10.2 Latin America, Middle East and Africa Microbiome Drugs Market, by Application
-
10.3 Latin America, Middle East and Africa Microbiome Drugs Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Microbiome Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Microbiome Drugs Company Profiles
-
11.1 Rebiotix
-
11.1.1 Rebiotix Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Rebiotix Microbiome Drugs Product Profiles, Application and Specification
-
11.1.3 Rebiotix Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 OpenBiome
-
11.2.1 OpenBiome Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 OpenBiome Microbiome Drugs Product Profiles, Application and Specification
-
11.2.3 OpenBiome Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Seres Therapeutics
-
11.3.1 Seres Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Seres Therapeutics Microbiome Drugs Product Profiles, Application and Specification
-
11.3.3 Seres Therapeutics Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Second Genome
-
11.4.1 Second Genome Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Second Genome Microbiome Drugs Product Profiles, Application and Specification
-
11.4.3 Second Genome Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 MaaT Pharma
-
11.5.1 MaaT Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 MaaT Pharma Microbiome Drugs Product Profiles, Application and Specification
-
11.5.3 MaaT Pharma Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Pfizer
-
11.6.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Pfizer Microbiome Drugs Product Profiles, Application and Specification
-
11.6.3 Pfizer Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Enterome Bioscience
-
11.7.1 Enterome Bioscience Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Enterome Bioscience Microbiome Drugs Product Profiles, Application and Specification
-
11.7.3 Enterome Bioscience Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 MicroBiome Therapeutics
-
11.8.1 MicroBiome Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 MicroBiome Therapeutics Microbiome Drugs Product Profiles, Application and Specification
-
11.8.3 MicroBiome Therapeutics Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Ritter Pharmaceuticals
-
11.9.1 Ritter Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Ritter Pharmaceuticals Microbiome Drugs Product Profiles, Application and Specification
-
11.9.3 Ritter Pharmaceuticals Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Microbiome Drugs Industry Investment Prospect and Risk Assessment
-
12.1 Microbiome Drugs Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Microbiome Drugs Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Global Microbiome Drugs Production Value and Growth Rate (2017-2028)
-
Figure China Microbiome Drugs Production Value and Growth Rate (2017-2028)
-
Figure Global Microbiome Drugs Market Size and Growth Rate of Probiotics (2017-2028)
-
Figure Global Microbiome Drugs Market Size and Growth Rate of Prebiotics (2017-2028)
-
Figure Global Microbiome Drugs Market Size and Growth Rate of Small Molecules (2017-2028)
-
Figure Global Microbiome Drugs Market Size and Growth Rate of Biological Drugs (2017-2028)
-
Figure Global Microbiome Drugs Market Size and Growth Rate of Other (2017-2028)
-
Figure Global Microbiome Drugs Market Size and Growth Rate of Hospital Pharmacies (2017-2028)
-
Figure Global Microbiome Drugs Market Size and Growth Rate of Retail Pharmacies (2017-2028)
-
Figure Global Microbiome Drugs Market Size and Growth Rate of Online Pharmacies (2017-2028)
-
Figure Global Microbiome Drugs Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Microbiome Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Microbiome Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Microbiome Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Microbiome Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Microbiome Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Microbiome Drugs Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Microbiome Drugs Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Microbiome Drugs Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Microbiome Drugs Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Microbiome Drugs Market Share, by Manufacturer in 2021
-
Figure Global and China Microbiome Drugs Market Share, by Manufacturer in 2022
-
Table Global Microbiome Drugs Sales Volume, by Type (2017-2028)
-
Table Global Microbiome Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Global Microbiome Drugs Sales Volume Share, by Type (2017-2028)
-
Table Global Microbiome Drugs Sales Value, by Type (2017-2028)
-
Table Global Microbiome Drugs Sales Value Share, by Type (2017-2028)
-
Figure Global Microbiome Drugs Price Trend, by Type (2017-2028)
-
Table China Microbiome Drugs Sales Volume, by Type (2017-2028)
-
Table China Microbiome Drugs Sales Volume Share, by Type (2017-2028)
-
Figure China Microbiome Drugs Sales Volume Share, by Type (2017-2028)
-
Table China Microbiome Drugs Sales Value, by Type (2017-2028)
-
Table China Microbiome Drugs Sales Value Share, by Type (2017-2028)
-
Figure China Microbiome Drugs Price Trend, by Type (2017-2028)
-
Table Global Microbiome Drugs Sales Volume, by Application (2017-2028)
-
Table Global Microbiome Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Global Microbiome Drugs Sales Volume Share, by Application (2017-2028)
-
Table Global Microbiome Drugs Sales Value, by Application (2017-2028)
-
Table Global Microbiome Drugs Sales Value Share, by Application (2017-2028)
-
Figure Global Microbiome Drugs Sales Value Share, by Application (2017-2028)
-
Table China Microbiome Drugs Sales Volume, by Application (2017-2028)
-
Table China Microbiome Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Microbiome Drugs Sales Volume Share, by Application (2017-2028)
-
Table China Microbiome Drugs Sales Value, by Application (2017-2028)
-
Table China Microbiome Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Microbiome Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Microbiome Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure North America Microbiome Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Microbiome Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Microbiome Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Microbiome Drugs Production, Import, Consumption and Export (2017-2022)
-
Table North America Microbiome Drugs Sales Volume, by Type (2017-2028)
-
Table North America Microbiome Drugs Sales Volume Share, by Type (2017-2028)
-
Figure North America Microbiome Drugs Sales Volume Share, by Type (2017-2028)
-
Table North America Microbiome Drugs Sales Volume, by Application (2017-2028)
-
Table North America Microbiome Drugs Sales Volume Share, by Application (2017-2028)
-
Figure North America Microbiome Drugs Sales Volume Share, by Application (2017-2028)
-
Figure United States Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure United States Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Canada Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Table Europe Microbiome Drugs Sales Volume, by Type (2017-2028)
-
Table Europe Microbiome Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Europe Microbiome Drugs Sales Volume Share, by Type (2017-2028)
-
Table Europe Microbiome Drugs Sales Volume, by Application (2017-2028)
-
Table Europe Microbiome Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Europe Microbiome Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Germany Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure UK Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure UK Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure France Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure France Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Italy Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Spain Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Poland Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Russia Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Table APAC Microbiome Drugs Sales Volume, by Type (2017-2028)
-
Table APAC Microbiome Drugs Sales Volume Share, by Type (2017-2028)
-
Figure APAC Microbiome Drugs Sales Volume Share, by Type (2017-2028)
-
Table APAC Microbiome Drugs Sales Volume, by Application (2017-2028)
-
Table APAC Microbiome Drugs Sales Volume Share, by Application (2017-2028)
-
Figure APAC Microbiome Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Japan Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure India Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure India Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Microbiome Drugs Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Microbiome Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Microbiome Drugs Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Microbiome Drugs Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Microbiome Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Microbiome Drugs Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Microbiome Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Microbiome Drugs Sales Value and Growth Rate (2017-2028)
-
Table Rebiotix Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Rebiotix Product Profiles, Application and Specification
-
Table Rebiotix Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table OpenBiome Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table OpenBiome Product Profiles, Application and Specification
-
Table OpenBiome Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Seres Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Seres Therapeutics Product Profiles, Application and Specification
-
Table Seres Therapeutics Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Second Genome Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Second Genome Product Profiles, Application and Specification
-
Table Second Genome Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table MaaT Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table MaaT Pharma Product Profiles, Application and Specification
-
Table MaaT Pharma Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Enterome Bioscience Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Enterome Bioscience Product Profiles, Application and Specification
-
Table Enterome Bioscience Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table MicroBiome Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table MicroBiome Therapeutics Product Profiles, Application and Specification
-
Table MicroBiome Therapeutics Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ritter Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ritter Pharmaceuticals Product Profiles, Application and Specification
-
Table Ritter Pharmaceuticals Microbiome Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
